Genetic screening for inactivating variants in the calcium-sensing receptor (<i>CASR</i>) gene that are causative of FHH assists with the diagnosis since such variants are not generally associated with PHPT. This evidence concerns the gene CASR and familial hypocalciuric hypercalcemia.